Maybe Bill Ackman should not have invested such a high percent of his hedge fund into a un-ethical price-gouging pharmaceutical company (Valeant).
The fraud is not so much my concern- it's the unethical business plan. Valeant is just a watered down Turing Pharma. All the while Ackman continued to grow his position.
Clearly their research goes much deeper than reading over the 10Q forms and annual reports.